Invivyd Inc
IVVD
Get informed when a big investor buys or sells
+ FollowMarket Cap$262.7M
Close$
$4.30
381.7% upside
Current Fair Value
381.7% upsideUndervalued by 381.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $262.70 Million |
|---|---|
| Enterprise Value | $87.17 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.3 |
| Beta | 0.63 |
| Outstanding Shares | 309,670,101 |
Return
| Return on Equity | -38.22% |
|---|---|
| Return on Assets | -32.10% |
| Return on Invested Capital | -39.13% |
Valuation & Multiples
| P/E Ratio | -2.38 |
|---|---|
| PEG | -1.55 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.56 |
| Enterprise Value to EBIT | -1.06 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 21, 2026
EPS Estimate
$-0.08
Average shareholder expectationRevenue Estimate
$18.04 M
Average shareholder expectationNext Earnings Call
Expected Date
August 13, 2026
EPS Estimate
$-0.15
Average shareholder expectationRevenue Estimate
$14.40 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.3663▼ 22.50% |
|---|---|
| Total Calls | 561,000▼ 19.97% |
| Total Puts | 205,500▼ 50.42% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 131.50%▼ 9.63% |
|---|---|
| Total Invested | $294.24M▼ 50.44% |
| Investors Holding | 146▲ 25.00% |
ESG Score
No data
About Invivyd Inc
2,021 employeesAdagio (Nasdaq: ADGI) is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company’s portfolio of antib...